Ulipristal acetate - safety and pharmacokinetics following multiple doses of 10-50 mg per day
Pohl, O., Osterloh, I., Gotteland, J.-P.
Published in Journal of clinical pharmacy and therapeutics (01.08.2013)
Published in Journal of clinical pharmacy and therapeutics (01.08.2013)
Get full text
Journal Article
Inhibition of steroid sulfatase decreases endometriosis in an in vivo murine model
Colette, S., Defrère, S., Lousse, J.C., Van Langendonckt, A., Gotteland, J.P., Loumaye, E., Donnez, J.
Published in Human reproduction (Oxford) (01.06.2011)
Published in Human reproduction (Oxford) (01.06.2011)
Get full text
Journal Article
Effects of erythromycin at steady-state concentrations on the pharmacokinetics of ulipristal acetate
Pohl, O., Osterloh, I., Gotteland, J-P
Published in Journal of clinical pharmacy and therapeutics (01.12.2013)
Published in Journal of clinical pharmacy and therapeutics (01.12.2013)
Get full text
Journal Article
AS601245, a c‐Jun NH2‐terminal kinase (JNK) inhibitor, reduces axon/dendrite damage and cognitive deficits after global cerebral ischaemia in gerbils
Carboni, S, Boschert, U, Gaillard, P, Gotteland, J‐P, Gillon, J‐Y, Vitte, P‐A
Published in British journal of pharmacology (01.01.2008)
Published in British journal of pharmacology (01.01.2008)
Get full text
Journal Article
AS601245, a c‐Jun NH 2 ‐terminal kinase (JNK) inhibitor, reduces axon/dendrite damage and cognitive deficits after global cerebral ischaemia in gerbils
Carboni, S, Boschert, U, Gaillard, P, Gotteland, J‐P, Gillon, J‐Y, Vitte, P‐A
Published in British journal of pharmacology (29.01.2009)
Published in British journal of pharmacology (29.01.2009)
Get full text
Journal Article
Design and synthesis of new potential photoaffinity labels for mammalian squalene epoxidase
Gotteland, J.-P., Dax, C., Halazy, S.
Published in Bioorganic & medicinal chemistry letters (06.05.1997)
Published in Bioorganic & medicinal chemistry letters (06.05.1997)
Get full text
Journal Article
Sulfonamide derivatives of benzylamine block cholesterol biosynthesis in HepG2 cells : A new type of potent squalene epoxidase inhibitors
GOTTELAND, J.-P, LOUBAT, C, PLANTY, B, JUNQUERO, D, DELHON, A, HALAZY, S
Published in Bioorganic & medicinal chemistry letters (02.06.1998)
Published in Bioorganic & medicinal chemistry letters (02.06.1998)
Get full text
Journal Article
Design and synthesis of new hypocholesterolemic organosilanes with antioxidant properties
Gotteland, J.-P., Delhon, A., Junquéro, D., Oms, P., Halazy, S.
Published in Bioorganic & medicinal chemistry letters (05.03.1996)
Published in Bioorganic & medicinal chemistry letters (05.03.1996)
Get full text
Journal Article
(Aryloxy)methylsilane Derivatives as New Cholesterol Biosynthesis Inhibitors: Synthesis and Hypocholesterolemic Activity of a New Class of Squalene Epoxidase Inhibitors
Gotteland, Jean-Pierre, Brunel, Isabelle, Gendre, Fabrice, Desire, Jerome, Delhon, Andre, Junquero, Didier, Oms, Philippe, Halazy, Serge
Published in Journal of medicinal chemistry (01.08.1995)
Published in Journal of medicinal chemistry (01.08.1995)
Get full text
Journal Article
Design, Synthesis, and Biological Activity of Novel, Potent, and Selective (Benzoylaminomethyl)thiophene Sulfonamide Inhibitors of c-Jun-N-Terminal Kinase
Rückle, Thomas, Biamonte, Marco, Grippi-Vallotton, Tania, Arkinstall, Steve, Cambet, Yves, Camps, Montserrat, Chabert, Christian, Church, Dennis J, Halazy, Serge, Jiang, Xuliang, Martinou, Isabelle, Nichols, Anthony, Sauer, Wolfgang, Gotteland, Jean-Pierre
Published in Journal of medicinal chemistry (30.12.2004)
Published in Journal of medicinal chemistry (30.12.2004)
Get full text
Journal Article
O-135 Long term secondary efficacy of linzagolix for heavy menstrual bleeding (HMB) due to uterine fibroids (UF): 52-week results from two placebo-controlled, randomized, phase 3 trials
Taylor, H, Donnez, J, Petraglia, F, Gemzell Danielsson, K, Renner, S, Bestel, E, Gotteland, J P, Humberstone, A, Garner, E
Published in Human reproduction (Oxford) (06.08.2021)
Published in Human reproduction (Oxford) (06.08.2021)
Get full text
Journal Article
AS601245, a c-Jun NH sub(2)-terminal kinase (JNK) inhibitor, reduces axon/dendrite damage and cognitive deficits after global cerebral ischaemia in gerbils
Carboni, S, Boschert, U, Gaillard, P, Gotteland, J-P, Gillon, J-Y, Vitte, P-A
Published in British journal of pharmacology (01.01.2008)
Published in British journal of pharmacology (01.01.2008)
Get full text
Journal Article
TRANSLATIONAL RESEARCH
Rosenbluth, E. M., Wells, L. M., Sparks, A. E., Van Voorhis, B. J., Reyes-Palomares, A., Palomares, A. R., Medina, M. A., Ruiz Galdon, M., Reyes Engel, A., Stanghellini, I., Luiselli, D., Magli, M. C., Lang, M., Romeo, G., Ferraretti, A. P., Gianaroli, L., Gun Eryilmaz, O., Sarikaya, E., Yilmaz, S., Avci, A., Ozogul, C., Barun, S., Genc, M., Kitsou, C., Kosmas, I., Peschos, D., Euaggelou, A., Lazaros, L., Stefos, T., Tournaye, H., Prapa, S., Prapas, N., Prapas, Y., Zikopoulos, K., Georgiou, I., Loewke, K., Moussavi, F., Maddah, M., Conaghan, J., Ivani, K., Suraj, V., Chen, A., Shen, S., Dittrich, R., Hoffmann, I., Kunzel, J., Lotz, L., Mueller, A., Reissmann, C., Hildebrandt, T., Hakl, J., Unluhan, N., Oppelt, P. G., Beckmann, M. W., Huszar, G., Geerts, N., McGrath, J., Vanderlick, K., Pohl, O., Gotteland, J. P., Bestel, E., Sinai Talaulikar, V., Manyonda, I.
Published in Human reproduction (Oxford) (01.07.2012)
Published in Human reproduction (Oxford) (01.07.2012)
Get full text
Journal Article
LINZAGOLIX FOR ENDOMETRIOSIS-ASSOCIATED PAIN: SAFETY RESULTS FROM EDELWEISS 3, A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
Donnez, J, Taylor, H, Gemzell-Danielsson, K, Catherino, W, Bestel, E, Gotteland, JP, Humberstone, A, Moore, L, Garner, E
Published in HUMAN REPRODUCTION (2022)
Get full text
Published in HUMAN REPRODUCTION (2022)
Conference Proceeding
Long term secondary efficacy of linzagolix for heavy menstrual bleeding (HMB) due to uterine fibroids (UF): 52-week results from two placebo-controlled, randomized, phase 3 trials
Taylor, H, Donnez, J, Petraglia, F, Danielsson, KG, Renner, S, Bestel, E, Gotteland, JP, Humberstone, A, Garner, E
Published in HUMAN REPRODUCTION (2021)
Get full text
Published in HUMAN REPRODUCTION (2021)
Conference Proceeding
Inhibition of c‐Jun N‐terminal kinase decreases cardiomyocyte apoptosis and infarct size after myocardial ischemia and reperfusion in anaesthetized rats
Ferrandi, Chiara, Ballerio, Rossana, Gaillard, Pascale, Giachetti, Claudio, Carboni, Sonia, Vitte, Pierre‐Alain, Gotteland, Jean‐Pierre, Cirillo, Rocco
Published in British journal of pharmacology (01.07.2004)
Published in British journal of pharmacology (01.07.2004)
Get full text
Journal Article
Design and Synthesis of the First Generation of Novel Potent, Selective, and in Vivo Active (Benzothiazol-2-yl)acetonitrile Inhibitors of the c-Jun N-Terminal Kinase
Gaillard, Pascale, Jeanclaude-Etter, Isabelle, Ardissone, Vittoria, Arkinstall, Steve, Cambet, Yves, Camps, Montserrat, Chabert, Christian, Church, Dennis, Cirillo, Rocco, Gretener, Denise, Halazy, Serge, Nichols, Anthony, Szyndralewiez, Cedric, Vitte, Pierre-Alain, Gotteland, Jean-Pierre
Published in Journal of medicinal chemistry (14.07.2005)
Published in Journal of medicinal chemistry (14.07.2005)
Get full text
Journal Article
AS601245 (1,3-Benzothiazol-2-yl (2-{[2-(3-pyridinyl) ethyl] amino}-4 pyrimidinyl) Acetonitrile): A c-Jun NH2-Terminal Protein Kinase Inhibitor with Neuroprotective Properties
Carboni, Sonia, Hiver, Agnes, Szyndralewiez, Cedric, Gaillard, Pascale, Gotteland, Jean-Pierre, Vitte, Pierre-Alain
Published in The Journal of pharmacology and experimental therapeutics (01.07.2004)
Published in The Journal of pharmacology and experimental therapeutics (01.07.2004)
Get full text
Journal Article